Stocktoria
PMV Pharmaceuticals, Inc. PMVP
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-09-25
Chart by TradingView
1/9
Piotroski F — financial health
-2.34
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$86.2M | -$85.4M | -$80.1M | -$77.0M | -$58.3M |
| Net income | -$77.7M | -$58.7M | -$69.0M | -$73.3M | -$57.8M |
| Operating cash flow | -$73.6M | -$51.3M | -$55.7M | -$63.8M | -$46.6M |
| Free cash flow | -$73.6M | -$51.9M | -$56.6M | -$71.7M | -$47.9M |
| Total assets | $116.6M | $191.3M | $252.2M | $270.3M | $331.6M |
| Total liabilities | $11.8M | $15.2M | $26.5M | $24.3M | $23.0M |
| Shareholders' equity | $104.7M | $176.1M | $225.7M | $246.0M | $308.6M |
| Ratios | |||||
| Return on assets | -66.7% | -30.7% | -27.3% | -27.1% | -17.4% |
| Return on equity | -74.2% | -33.3% | -30.6% | -29.8% | -18.7% |
| Current ratio | 10.09 | 12.22 | 14.78 | 22.80 | 24.66 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 20,945 | $25,972 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -2.34 (distress)
- Working capital / assets 0.891
- Retained earnings / assets -3.83
- EBIT / assets -0.74
- Equity / liabilities 8.836
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001699382 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.